Biotech

All Articles

Vir gains 3 T-cell engagers from Sanofi, gives up 25% of team

.Vir Biotechnology's second-quarter revenues record wasn't except major headlines. The business acce...

Galapagos stops briefly CAR-T tissue treatment hearing over Parkinsonism situation

.Galapagos has stopped briefly enrollment in a trial of a BCMA-directed CAR-T cell therapy, pushing ...

James Wilson leaving Penn to introduce two brand new biotechs

.After much more than thirty years, genetics therapy trendsetter James Wilson M.D., Ph.D., is actual...

3 biotechs make an effort to beat the summer months warmth by shedding personnel

.As biotechs seek to transform a new webpage in August, a minimum of three firms have lost team in e...

venBio raises $528M for fifth lifestyle scientific researches VC fund

.Professional financial backing agency venBio has lifted another half a billion dollars to buy biote...

Otsuka spends $800M for Jnana and also its clinical-stage PKU medicine

.Otsuka Pharmaceutical has actually picked up Boston-based Jnana Rehabs for $800 thousand so the Ori...

FibroGen lays off 75% people staff as property flunks 2 even more trials

.FibroGen is actually radically restructuring its own organization, giving up 75% of its own united ...

Tracon wane weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has decided to relax functions weeks after an injectable invulnerable checkp...

Ideaya bags option on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on stopped working epilepsy drug, touts FDA operate

.Our experts actually recognize that Takeda is hoping to find a path to the FDA for epilepsy medicat...